NCT00806247View on ClinicalTrials.gov

A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of Tapentadol IR for Postoperative Pain Following Bunionectomy Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

480

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

August 31, 2005

Conditions

PainPostoperative Pain

Interventions

DRUG

tapentadol HCl

Sponsors

Collaborators (1)

Grünenthal GmbH

All Listed Sponsors

collaborator

Grünenthal GmbH

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY